Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab treatment beyond progression with second-line chemotherapy in HER2-positive metastatic breast cancer
2006-002860-25Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of trastuzumab in breast cancer (2 arms), sponsored by Roche. Primary endpoint: Time to disease progression. Started Aug 2006; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-002860-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002860-25.